In the landscape of peptide research, few compounds have generated as much sustained scientific interest as Epithalon. This synthetic tetrapeptide — composed of just four amino acids (Ala-Glu-Asp-Gly, or AEDG) — sits at the intersection of telomere biology, neuroendocrine regulation, and the broader science of aging. First synthesized in the late 1990s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, Epithalon was designed as a cleaner, reproducible analog of Epithalamin, a peptide extract derived from bovine pineal glands.
This article is intended for educational and informational purposes only. All peptides referenced are sold strictly for laboratory research use. They are not intended for human or animal consumption.
What makes Epithalon remarkable is not just one mechanism but rather a convergence of biological activities. Over the past 25 years, published research has linked this small molecule to telomerase activation, melatonin normalization, antioxidant gene upregulation, and neuroprotective effects — making it one of the most broadly studied peptides in the aging research field.
The story of Epithalon begins with Epithalamin, a crude polypeptide extract from the pineal glands of cattle. Beginning in the 1970s, Khavinson and colleagues observed that this extract could restore age-related functional decline in neuroendocrine tissues when administered to aging animal models. The challenge was reproducibility: natural extracts vary from batch to batch.
To solve this, Khavinson’s group systematically isolated the shortest active peptide sequence responsible for the observed biological effects, arriving at the tetrapeptide AEDG. The synthetic version, named Epithalon, was patented in 2000 and has since been the subject of hundreds of published studies spanning in vitro cell culture, in vivo animal models, and limited human investigations (Khavinson, 2002).
Telomerase Activation: The Core Mechanism
The most widely cited property of Epithalon is its capacity to activate telomerase, the enzyme responsible for maintaining telomere length at the ends of chromosomes. Telomeres shorten with each cell division, and their progressive erosion is one of the hallmarks of cellular aging.
In a foundational 2003 study, Khavinson and colleagues demonstrated that adding Epithalon to cultures of telomerase-negative human fetal fibroblasts induced expression of the catalytic subunit hTERT, reactivated telomerase enzymatic activity, and produced measurable telomere elongation (Khavinson et al., 2003).
A landmark 2025 study from Brunel University London — notably the first detailed independent investigation outside Khavinson’s group — provided quantitative confirmation. Al-Dulaimi and colleagues tested Epithalon across multiple human cell lines and found that in normal mammary epithelial cells, the peptide upregulated hTERT mRNA expression and increased telomerase activity, extending telomeres from 2.4 kb to 4 kb at concentrations of 0.5 and 1 micrograms per milliliter. Intriguingly, in cancer cell lines the peptide engaged the alternative lengthening of telomeres (ALT) pathway instead, suggesting cell-type-dependent mechanisms (Al-Dulaimi et al., 2025).
Melatonin Regulation and Circadian Rhythm Restoration
As a peptide derived from pineal gland biology, Epithalon’s relationship with melatonin is well-documented. Aging is associated with declining melatonin production and a flattening of circadian rhythm amplitude — changes that cascade into disrupted sleep architecture, impaired immune function, and altered antioxidant capacity.
Research in aged rhesus monkeys and elderly human subjects demonstrated that Epithalon recovers nighttime melatonin release and normalizes the hormone’s circadian rhythm in blood plasma, with no adverse effects observed (Korkushko et al., 2007). A separate investigation in a female cohort showed that sublingual administration at 0.5 mg per day for 20 days enhanced melatonin synthesis by 1.6-fold relative to placebo.
These findings position Epithalon alongside compounds like NAD+ and MOTS-c as peptides with relevance to circadian biology and age-related neuroendocrine decline.
All compounds discussed in this article are for laboratory research purposes only. Nothing in this article constitutes medical advice or a recommendation for human use.
Beyond telomerase and melatonin, Epithalon has demonstrated antioxidant activity through upregulation of endogenous defense enzymes. Studies have documented increased expression of genes encoding superoxide dismutase (SOD-1), NAD(P)H quinone dehydrogenase (NQO1), and catalase in human cells exposed to the peptide, potentially through interaction with the Keap1/Nrf2 signaling pathway (Araj et al., 2025).
The neuroprotective dimension of Epithalon research has gained momentum as well. A 2020 study showed that the AEDG peptide stimulated neurogenic differentiation in human gingival mesenchymal stem cells, increasing expression of markers including Nestin, GAP43, beta-tubulin III, and Doublecortin by 1.6 to 1.8 times. Molecular modeling revealed that the peptide preferentially binds histone proteins H1/3 and H1/6 at DNA-interacting sites, suggesting an epigenetic mechanism of gene regulation (Khavinson et al., 2020).
A 2025 study extended this work into ophthalmology, demonstrating that Epithalon restored impaired wound healing in a high-glucose in vitro model of diabetic retinopathy by reducing reactive oxygen species, restoring antioxidant gene expression (SOD2, CAT, HMOX1), and inhibiting fibrosis pathways (Gatta et al., 2025). Earlier work had shown positive retinal effects in animal models of retinitis pigmentosa (Khavinson et al., 2002).
Lifespan Studies: From Fruit Flies to Mice
Some of the most striking Epithalon data comes from animal longevity studies. In Drosophila melanogaster, the peptide increased lifespan by 11 to 16 percent at concentrations 16,000 to 80,000,000 times lower than those required for melatonin to produce comparable effects (Khavinson et al., 2000).
In female Swiss-derived SHR mice receiving monthly subcutaneous injections from age three months, Epithalon increased maximum lifespan by 12.3 percent, decreased chromosomal aberrations in bone marrow cells by 17.1 percent, slowed age-related loss of estrous function, and inhibited leukemia development six-fold — all without affecting body weight or food consumption (Anisimov et al., 2003).
These animal studies, while compelling, come with important caveats. Virtually all originate from the Khavinson and Anisimov laboratories, and none have been replicated through programs like the National Institute on Aging Interventions Testing Program (NIA ITP).
The Broader Peptide Bioregulation Framework
Epithalon does not exist in isolation. It belongs to a class of short peptides that Khavinson spent four decades investigating under the framework of peptide bioregulation — the hypothesis that age-related decline results from changes in gene expression that can be corrected through targeted peptide administration. Other peptides in this framework include Thymalin (thymus), Cortexin (brain cortex), and Retinalamin (retina).
This broader context is relevant because it situates Epithalon alongside other research compounds of interest to aging science, including GHK-Cu for tissue remodeling, SS-31 (Elamipretide) for mitochondrial protection, and NAD+ for metabolic regulation. Each addresses different hallmarks of aging, and researchers continue to explore how these pathways may interact.
Products mentioned in this article are intended for in vitro research and laboratory investigation only. They are not approved for any therapeutic use. Always consult qualified professionals for health-related decisions.
What the Research Still Needs
Despite 25 years of published data, Epithalon’s precise mechanism of action remains incompletely understood. The 2025 comprehensive review in the International Journal of Molecular Sciences noted that while the compound’s geroprotective, neuroendocrine, antioxidant, neuroprotective, and antimutagenic effects have been documented across multiple experimental paradigms, the molecular pathway connecting the four-amino-acid sequence to these diverse outcomes is still being mapped (Araj et al., 2025).
The 2025 Brunel University study represents a significant step forward as the first fully independent replication of Epithalon’s telomere-extending effects, but the field needs more such efforts. Larger-scale, blinded, multicenter studies — particularly in animal models through established programs — would substantially strengthen the evidence base.
For researchers studying the biology of aging, Epithalon remains a compelling subject of investigation precisely because of how many aging hallmarks it appears to touch. All of our research peptides are tested for purity and identity — view our third-party lab results for complete documentation.
Epithalon is a synthetic tetrapeptide consisting of four amino acids: alanine, glutamic acid, aspartic acid, and glycine (Ala-Glu-Asp-Gly, abbreviated AEDG). It was designed as a synthetic analog of Epithalamin, a peptide extract originally isolated from bovine pineal glands.
How does Epithalon relate to telomerase research?
Published studies have demonstrated that Epithalon can induce expression of the hTERT catalytic subunit and activate telomerase enzymatic activity in human cell cultures, leading to measurable telomere elongation. A 2025 independent study confirmed these findings across multiple cell types and provided the first quantitative dose-response data.
What is the connection between Epithalon and melatonin?
As a peptide derived from pineal gland biology, Epithalon has been shown in research to stimulate melatonin biosynthesis and normalize age-related disruptions in circadian melatonin rhythm. Studies in aged primates and elderly human subjects documented restoration of nighttime melatonin peaks following administration.
Has Epithalon been studied in animal lifespan models?
Yes. Epithalon increased lifespan by 11 to 16 percent in Drosophila melanogaster and extended maximum lifespan by 12.3 percent in SHR mice while reducing chromosomal aberrations and inhibiting leukemia development. These studies were conducted primarily by the Khavinson-Anisimov research group.
What antioxidant effects has Epithalon shown in research?
Studies have documented Epithalon-induced upregulation of SOD-1, NQO1, catalase, and other antioxidant enzymes, potentially through the Keap1/Nrf2 pathway. A 2025 study demonstrated that the peptide restored antioxidant gene expression (SOD2, CAT, HMOX1) in a high-glucose retinal cell model.
Is Epithalon approved for any medical use?
No. Epithalon is classified as a research peptide. While it has been studied in limited clinical settings primarily in Russia, it has not been approved by the FDA or any major regulatory body for therapeutic use. All Epithalon sold by Oath Research is strictly for laboratory research purposes.
What distinguishes Epithalon from other aging-related research peptides?
Epithalon is notable for acting across multiple hallmarks of aging simultaneously — telomere maintenance, circadian rhythm regulation, antioxidant defense, and neuroprotection. Most other peptides in longevity research tend to target a single pathway, such as mitochondrial function (SS-31) or tissue repair (GHK-Cu).
References
Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L. Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025;26(6):2691. PubMed
Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025;26(5):178. PubMed
Gatta M, Dovizio M, Milillo C, et al. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy. Stem Cell Rev Rep. 2025;21(6):1822-1834. PubMed
Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PubMed
Khavinson V, Diomede F, Mironova E, et al. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules. 2020;25(3):609. PubMed
Korkushko OV, Lapin BA, Goncharova ND, et al. Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people. Adv Gerontol. 2007;20(1):74-85. PubMed
Anisimov VN, Khavinson VK, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. PubMed
Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mech Ageing Dev. 2000;120(1-3):141-149. PubMed
Khavinson VK. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23(Suppl 3):11-144. PubMed
Khavinson V, Razumovsky M, Trofimova S, Grigorian R, Razumovskaya A. Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. Neuro Endocrinol Lett. 2002;23(4):365-368. PubMed
Arutjunyan A, Kozina L, Milyutina Y, et al. Melatonin and pineal gland peptides are able to correct the impairment of reproductive cycles in rats. Curr Aging Sci. 2012;5(3):178-185. PubMed
Khavinson V, Linkova N, Dyatlova A, Kantemirova R, Kozlov K. Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation. Cells. 2023;12(1):106. PubMed
Exciting clinical trials have put thymosin alpha‑1, a powerful immune peptide, in the spotlight for its impressive ability to boost the body’s natural defenses. Discover how recent breakthroughs are reshaping immune peptide research and opening new doors for disease prevention strategies.
Can I use peptides while breastfeeding? This is a critical question for nursing mothers. The short answer is that most peptides should be avoided during lactation due to limited safety data. Let’s explore why this caution exists and what you need to know. Understanding Drug Transfer to Breast Milk When you take any medication or …
The old-school approach to healing a soft-tissue injury might actually be slowing you down. Discover how tiny protein fragments called peptides are rewriting the playbook on recovery by speaking directly to your cells.
If you’re wondering “What is CJC-1295 Ipamorelin?” you’re asking the right question. This peptide combination has gained attention in research communities for its unique approach to stimulating growth hormone. Let me break down what makes this combination stand out, how it works, and what current research tells us about its potential applications. Understanding CJC-1295 and …
What Is Epithalon? The Tetrapeptide at the Center of Aging Research
A Quarter-Century of Research on Four Amino Acids
In the landscape of peptide research, few compounds have generated as much sustained scientific interest as Epithalon. This synthetic tetrapeptide — composed of just four amino acids (Ala-Glu-Asp-Gly, or AEDG) — sits at the intersection of telomere biology, neuroendocrine regulation, and the broader science of aging. First synthesized in the late 1990s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, Epithalon was designed as a cleaner, reproducible analog of Epithalamin, a peptide extract derived from bovine pineal glands.
This article is intended for educational and informational purposes only. All peptides referenced are sold strictly for laboratory research use. They are not intended for human or animal consumption.
What makes Epithalon remarkable is not just one mechanism but rather a convergence of biological activities. Over the past 25 years, published research has linked this small molecule to telomerase activation, melatonin normalization, antioxidant gene upregulation, and neuroprotective effects — making it one of the most broadly studied peptides in the aging research field.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.From Pineal Extracts to Synthetic Tetrapeptide
The story of Epithalon begins with Epithalamin, a crude polypeptide extract from the pineal glands of cattle. Beginning in the 1970s, Khavinson and colleagues observed that this extract could restore age-related functional decline in neuroendocrine tissues when administered to aging animal models. The challenge was reproducibility: natural extracts vary from batch to batch.
To solve this, Khavinson’s group systematically isolated the shortest active peptide sequence responsible for the observed biological effects, arriving at the tetrapeptide AEDG. The synthetic version, named Epithalon, was patented in 2000 and has since been the subject of hundreds of published studies spanning in vitro cell culture, in vivo animal models, and limited human investigations (Khavinson, 2002).
Telomerase Activation: The Core Mechanism
The most widely cited property of Epithalon is its capacity to activate telomerase, the enzyme responsible for maintaining telomere length at the ends of chromosomes. Telomeres shorten with each cell division, and their progressive erosion is one of the hallmarks of cellular aging.
In a foundational 2003 study, Khavinson and colleagues demonstrated that adding Epithalon to cultures of telomerase-negative human fetal fibroblasts induced expression of the catalytic subunit hTERT, reactivated telomerase enzymatic activity, and produced measurable telomere elongation (Khavinson et al., 2003).
A landmark 2025 study from Brunel University London — notably the first detailed independent investigation outside Khavinson’s group — provided quantitative confirmation. Al-Dulaimi and colleagues tested Epithalon across multiple human cell lines and found that in normal mammary epithelial cells, the peptide upregulated hTERT mRNA expression and increased telomerase activity, extending telomeres from 2.4 kb to 4 kb at concentrations of 0.5 and 1 micrograms per milliliter. Intriguingly, in cancer cell lines the peptide engaged the alternative lengthening of telomeres (ALT) pathway instead, suggesting cell-type-dependent mechanisms (Al-Dulaimi et al., 2025).
Melatonin Regulation and Circadian Rhythm Restoration
As a peptide derived from pineal gland biology, Epithalon’s relationship with melatonin is well-documented. Aging is associated with declining melatonin production and a flattening of circadian rhythm amplitude — changes that cascade into disrupted sleep architecture, impaired immune function, and altered antioxidant capacity.
Research in aged rhesus monkeys and elderly human subjects demonstrated that Epithalon recovers nighttime melatonin release and normalizes the hormone’s circadian rhythm in blood plasma, with no adverse effects observed (Korkushko et al., 2007). A separate investigation in a female cohort showed that sublingual administration at 0.5 mg per day for 20 days enhanced melatonin synthesis by 1.6-fold relative to placebo.
These findings position Epithalon alongside compounds like NAD+ and MOTS-c as peptides with relevance to circadian biology and age-related neuroendocrine decline.
All compounds discussed in this article are for laboratory research purposes only. Nothing in this article constitutes medical advice or a recommendation for human use.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Antioxidant and Neuroprotective Properties
Beyond telomerase and melatonin, Epithalon has demonstrated antioxidant activity through upregulation of endogenous defense enzymes. Studies have documented increased expression of genes encoding superoxide dismutase (SOD-1), NAD(P)H quinone dehydrogenase (NQO1), and catalase in human cells exposed to the peptide, potentially through interaction with the Keap1/Nrf2 signaling pathway (Araj et al., 2025).
The neuroprotective dimension of Epithalon research has gained momentum as well. A 2020 study showed that the AEDG peptide stimulated neurogenic differentiation in human gingival mesenchymal stem cells, increasing expression of markers including Nestin, GAP43, beta-tubulin III, and Doublecortin by 1.6 to 1.8 times. Molecular modeling revealed that the peptide preferentially binds histone proteins H1/3 and H1/6 at DNA-interacting sites, suggesting an epigenetic mechanism of gene regulation (Khavinson et al., 2020).
A 2025 study extended this work into ophthalmology, demonstrating that Epithalon restored impaired wound healing in a high-glucose in vitro model of diabetic retinopathy by reducing reactive oxygen species, restoring antioxidant gene expression (SOD2, CAT, HMOX1), and inhibiting fibrosis pathways (Gatta et al., 2025). Earlier work had shown positive retinal effects in animal models of retinitis pigmentosa (Khavinson et al., 2002).
Lifespan Studies: From Fruit Flies to Mice
Some of the most striking Epithalon data comes from animal longevity studies. In Drosophila melanogaster, the peptide increased lifespan by 11 to 16 percent at concentrations 16,000 to 80,000,000 times lower than those required for melatonin to produce comparable effects (Khavinson et al., 2000).
In female Swiss-derived SHR mice receiving monthly subcutaneous injections from age three months, Epithalon increased maximum lifespan by 12.3 percent, decreased chromosomal aberrations in bone marrow cells by 17.1 percent, slowed age-related loss of estrous function, and inhibited leukemia development six-fold — all without affecting body weight or food consumption (Anisimov et al., 2003).
These animal studies, while compelling, come with important caveats. Virtually all originate from the Khavinson and Anisimov laboratories, and none have been replicated through programs like the National Institute on Aging Interventions Testing Program (NIA ITP).
The Broader Peptide Bioregulation Framework
Epithalon does not exist in isolation. It belongs to a class of short peptides that Khavinson spent four decades investigating under the framework of peptide bioregulation — the hypothesis that age-related decline results from changes in gene expression that can be corrected through targeted peptide administration. Other peptides in this framework include Thymalin (thymus), Cortexin (brain cortex), and Retinalamin (retina).
This broader context is relevant because it situates Epithalon alongside other research compounds of interest to aging science, including GHK-Cu for tissue remodeling, SS-31 (Elamipretide) for mitochondrial protection, and NAD+ for metabolic regulation. Each addresses different hallmarks of aging, and researchers continue to explore how these pathways may interact.
Products mentioned in this article are intended for in vitro research and laboratory investigation only. They are not approved for any therapeutic use. Always consult qualified professionals for health-related decisions.
What the Research Still Needs
Despite 25 years of published data, Epithalon’s precise mechanism of action remains incompletely understood. The 2025 comprehensive review in the International Journal of Molecular Sciences noted that while the compound’s geroprotective, neuroendocrine, antioxidant, neuroprotective, and antimutagenic effects have been documented across multiple experimental paradigms, the molecular pathway connecting the four-amino-acid sequence to these diverse outcomes is still being mapped (Araj et al., 2025).
The 2025 Brunel University study represents a significant step forward as the first fully independent replication of Epithalon’s telomere-extending effects, but the field needs more such efforts. Larger-scale, blinded, multicenter studies — particularly in animal models through established programs — would substantially strengthen the evidence base.
For researchers studying the biology of aging, Epithalon remains a compelling subject of investigation precisely because of how many aging hallmarks it appears to touch. All of our research peptides are tested for purity and identity — view our third-party lab results for complete documentation.
$55.00Original price was: $55.00.$50.00Current price is: $50.00.Frequently Asked Questions
What is Epithalon made of?
Epithalon is a synthetic tetrapeptide consisting of four amino acids: alanine, glutamic acid, aspartic acid, and glycine (Ala-Glu-Asp-Gly, abbreviated AEDG). It was designed as a synthetic analog of Epithalamin, a peptide extract originally isolated from bovine pineal glands.
How does Epithalon relate to telomerase research?
Published studies have demonstrated that Epithalon can induce expression of the hTERT catalytic subunit and activate telomerase enzymatic activity in human cell cultures, leading to measurable telomere elongation. A 2025 independent study confirmed these findings across multiple cell types and provided the first quantitative dose-response data.
What is the connection between Epithalon and melatonin?
As a peptide derived from pineal gland biology, Epithalon has been shown in research to stimulate melatonin biosynthesis and normalize age-related disruptions in circadian melatonin rhythm. Studies in aged primates and elderly human subjects documented restoration of nighttime melatonin peaks following administration.
Has Epithalon been studied in animal lifespan models?
Yes. Epithalon increased lifespan by 11 to 16 percent in Drosophila melanogaster and extended maximum lifespan by 12.3 percent in SHR mice while reducing chromosomal aberrations and inhibiting leukemia development. These studies were conducted primarily by the Khavinson-Anisimov research group.
What antioxidant effects has Epithalon shown in research?
Studies have documented Epithalon-induced upregulation of SOD-1, NQO1, catalase, and other antioxidant enzymes, potentially through the Keap1/Nrf2 pathway. A 2025 study demonstrated that the peptide restored antioxidant gene expression (SOD2, CAT, HMOX1) in a high-glucose retinal cell model.
Is Epithalon approved for any medical use?
No. Epithalon is classified as a research peptide. While it has been studied in limited clinical settings primarily in Russia, it has not been approved by the FDA or any major regulatory body for therapeutic use. All Epithalon sold by Oath Research is strictly for laboratory research purposes.
What distinguishes Epithalon from other aging-related research peptides?
Epithalon is notable for acting across multiple hallmarks of aging simultaneously — telomere maintenance, circadian rhythm regulation, antioxidant defense, and neuroprotection. Most other peptides in longevity research tend to target a single pathway, such as mitochondrial function (SS-31) or tissue repair (GHK-Cu).
References
2 Day FAST Shipping
99%+ Purity Tests
Ships from Gilbert Arizona
USA Lab Tested
Free bacteriostatic water with every order.
Related Posts
Thymosin Alpha‑1: Stunning Immune Peptide Trials Revealed
Exciting clinical trials have put thymosin alpha‑1, a powerful immune peptide, in the spotlight for its impressive ability to boost the body’s natural defenses. Discover how recent breakthroughs are reshaping immune peptide research and opening new doors for disease prevention strategies.
Can I Use Peptides While Breastfeeding?
Can I use peptides while breastfeeding? This is a critical question for nursing mothers. The short answer is that most peptides should be avoided during lactation due to limited safety data. Let’s explore why this caution exists and what you need to know. Understanding Drug Transfer to Breast Milk When you take any medication or …
Can Peptides Outpace Traditional Injury Healing?
The old-school approach to healing a soft-tissue injury might actually be slowing you down. Discover how tiny protein fragments called peptides are rewriting the playbook on recovery by speaking directly to your cells.
What is CJC-1295 Ipamorelin?
If you’re wondering “What is CJC-1295 Ipamorelin?” you’re asking the right question. This peptide combination has gained attention in research communities for its unique approach to stimulating growth hormone. Let me break down what makes this combination stand out, how it works, and what current research tells us about its potential applications. Understanding CJC-1295 and …